임신 준비 영양제 시장 규모 - 성분, 형태, 최종 용도, 유통 채널, 지역별 전망 및 세계 예측(2023-2032년)

Fertility Supplements Market size is poised to record 8.7% CAGR from 2023-2032, on account of the rising imperative towards personalized medicine and nutrition.

The limitations of traditional pill formats and the strong emphasis on potentially improving compliance is leading to innovations in supplement delivery formats, including gummies, powders, and drinkable supplements. To quote an instance, in July 2023, the U.K.-based gummy vitamin brand Novomins unveiled a new range of women's gummies to support a variety of issues, such as menopause, PMS and fertility. The growing popularity of effervescent tablets as they add pleasant taste to supplements and enhance absorption will further drive the market growth.

The overall fertility supplements industry is segmented based on ingredients, form, end-use, and distribution channel and region.

In terms of form, the market value from the soft gels segment will witness 7.9% CAGR through 2032 led by the rising difficulties incurred during swallowing pills. Soft gel supplements are easier to swallow compared to traditional tablets and hard capsules. Due to their enhanced bioavailability, soft gels help the body to effectively absorb nutrients, such as vitamins, minerals, and antioxidants. The ongoing innovations for the introduction of new and improved soft gel formulations to meet the growing consumer expectations for fertility supplements with optimized formulations and delivery systems will also contribute to the segment growth.

Fertility supplements industry size from the prescribed distribution channel segment is expected to significantly expand at 7.6% CAGR up to 2032 owing to the higher advancements in reproductive health research. With the growing importance of male reproductive health in fertility equation, prescribed fertility supplements are witnessing increasing popularity as they help to target sperm quality, count, and motility.

Regionally, the Europe fertility supplements market size is expected to observe 9% CAGR through 2032. The increasing lifestyle changes, including sedentary habits, stress, and poor dietary choices are leading to multiple fertility issues, further driving the need for supplements to offer stress management and nutritional support. As per statistics from the World Infertility Awareness Month 2022, nearly 3.5 million people suffer from at least one form of fertility problem in the U.K. The surging trend of usage of natural and herbal ingredients in fertility supplements will also anchor the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Data sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Fertility supplements market 360 degree synopsis, 2018 - 2032
• 2.2 Business trends
  • 2.2.1 Total Addressable Market (TAM), 2023 - 2032
• 2.3 Regional trends
• 2.4 Ingredients trends
• 2.5 Form trends
• 2.6 End-use trends
• 2.7 Distribution channel trends

Chapter 3 Fertility Supplements Market Insights

• 3.1 Impact of COVID-19
• 3.2 Impact of the Russia-Ukraine war
• 3.3 Industry ecosystem analysis
• 3.4 Technology & innovation landscape
• 3.5 Patent analysis
• 3.6 Key news and initiatives
  • 3.6.1 Partnership/Collaboration
  • 3.6.2 Merger/Acquisition
  • 3.6.3 Investment
  • 3.6.4 Product launch & innovation
• 3.7 Regulatory landscape
• 3.8 Impact forces
  • 3.8.1 Growth drivers
    • 3.8.1.1 Rising prevalence of infertility
    • 3.8.1.2 Increased awareness of fertility supplements
    • 3.8.1.3 Supportive government initiatives
  • 3.8.2 Industry pitfalls & challenges
    • 3.8.2.1 Limited scientific evidence
    • 3.8.2.2 Potential side effects
• 3.9 Growth potential analysis
• 3.10 Porter's analysis
• 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company market share, 2022
• 4.3 Competitive analysis of major market players, 2022
  • 4.3.1 Fairhaven Health
  • 4.3.2 Coast Science
  • 4.3.3 Lenus Pharma GesmbH
  • 4.3.4 Active Bio Life Science GmbH
  • 4.3.5 Orthomol
  • 4.3.6 Exeltis USA, Inc.
  • 4.3.7 PregPrep LLC
  • 4.3.8 MegaFood
  • 4.3.9 Theralogix
  • 4.3.10 Fertility Nutraceuticals LLC
  • 4.3.11 Vitabiotics Ltd
  • 4.3.12 Zenith Nutrition
  • 4.3.13 GNC Holdings
  • 4.3.14 Nutraceutical Corporation
  • 4.3.15 Proxeed
• 4.4 Competitive positioning matrix, 2022
• 4.5 Strategic outlook matrix, 2022

Chapter 5 Fertility Supplements Market Estimates & Forecast, By Ingredients (Revenue)

• 5.1 Key trends, by ingredients
• 5.2 Natural
• 5.3 Synthetic

Chapter 6 Fertility Supplements Market Estimates & Forecast, By Form (Revenue)

• 6.1 Key trends, by form
• 6.2 Capsules
• 6.3 Tablets
• 6.4 Soft Gels
• 6.5 Powder
• 6.6 Liquids
• 6.7 Others

Chapter 7 Fertility Supplements Market Estimates & Forecast, By End-use (Revenue)

• 7.1 Key trends, by end-use
• 7.2 Men
• 7.3 Women

Chapter 8 Fertility Supplements Market Estimates & Forecast, By Distribution Channel (Revenue)

• 8.1 Key trends, by distribution channel
• 8.2 Over-the-counter (OTC)
• 8.3 Prescribed

Chapter 9 Fertility Supplements Market Estimates & Forecast, By Region (Revenue)

• 9.1 Key trends, by region
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 UK
  • 9.3.2 Germany
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Russia
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 South Korea
  • 9.4.5 Southeast Asia
  • 9.4.6 ANZ
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 MEA
  • 9.6.1 UAE
  • 9.6.2 Saudi Arabia
  • 9.6.3 South Africa

Chapter 10 Company Profiles

• 10.1 Fairhaven Health
• 10.2 Coast Science
• 10.3 Lenus Pharma GesmbH
• 10.4 Active Bio Life Science GmbH
• 10.5 Orthomol
• 10.6 Exeltis USA, Inc.
• 10.7 PregPrep LLC
• 10.8 MegaFood
• 10.9 Theralogix
• 10.10 Fertility Nutraceuticals LLC
• 10.11 Vitabiotics Ltd
• 10.12 Zenith Nutrition
• 10.13 GNC Holdings
• 10.14 Nutraceutical Corporation
• 10.15 Proxeed